- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- March 2024
- 186 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- May 2023
- 144 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- November 2023
- 142 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- October 2023
- 171 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- February 2024
- 118 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- August 2023
- 166 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- April 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,700GBP
- Report
- April 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,700GBP
- Report
- April 2024
- 64 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- April 2024
- 255 Pages
Global
From €7685EUR$7,950USD£6,606GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1450EUR$1,500USD£1,246GBP
The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more